CAS: 2193065-03-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 5-(trifluoromethyl)-1H,2H,3H-pyrrolo[2,3-b]pyridine hydrochloride REF: IN-DA01FK71CAS: 2193065-03-9 | 98% | 536.00 € | Mon 25 Nov 24 |
 | 5-(Trifluoromethyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine hydrochloride REF: 10-F667874CAS: 2193065-03-9 | 97% | To inquire | Thu 05 Dec 24 |
 | 5-(Trifluoromethyl)-1H,2H,3H-pyrrolo[2,3-b]pyridine hydrochloride REF: 3D-TMD06503CAS: 2193065-03-9 | Min. 95% | - - - | Discontinued product |
![5-(trifluoromethyl)-1H,2H,3H-pyrrolo[2,3-b]pyridine hydrochloride](https://static.cymitquimica.com/products/IN/thumb/DA01FK71.jpg)
5-(trifluoromethyl)-1H,2H,3H-pyrrolo[2,3-b]pyridine hydrochloride
CAS:2193065-03-9
Formula:
C8H8ClF3N2
Purity:
98%
Molecular weight:
224.6107
Ref: IN-DA01FK71
| 100mg | 536.00 € |
Estimated delivery in United States, on Monday 25 Nov 2024
![5-(Trifluoromethyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine hydrochloride](https://static.cymitquimica.com/products/10/thumb/F667874.jpg)
5-(Trifluoromethyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine hydrochloride
CAS:2193065-03-9
Purity:
97%
Molecular weight:
224.61000061035156
Ref: 10-F667874
| 1g | To inquire | ||
| 5g | To inquire | ||
| 2.5g | To inquire | ||
| 100mg | 448.00 € | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
![5-(Trifluoromethyl)-1H,2H,3H-pyrrolo[2,3-b]pyridine hydrochloride](https://static.cymitquimica.com/products/3D/thumb/TMD06503.jpg)
5-(Trifluoromethyl)-1H,2H,3H-pyrrolo[2,3-b]pyridine hydrochloride
CAS:2193065-03-9
Please enquire for more information about 5-(Trifluoromethyl)-1H,2H,3H-pyrrolo[2,3-b]pyridine hydrochloride including the price, delivery time and more …
Purity:
Min. 95%
Molecular weight:
224.6 g/mol
Ref: 3D-TMD06503
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
